The renaissance of complement therapeutics

D Ricklin, DC Mastellos, ES Reis… - Nature Reviews …, 2018 - nature.com
The increasing number of clinical conditions that involve a pathological contribution from the
complement system—many of which affect the kidneys—has spurred a regained interest in …

Complement-targeted therapeutics

D Ricklin, JD Lambris - Nature biotechnology, 2007 - nature.com
The complement system is a central component of innate immunity and bridges the innate to
the adaptive immune response. However, it can also turn its destructive capabilities against …

Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population

M Gaya da Costa, F Poppelaars, C Van Kooten… - Frontiers in …, 2018 - frontiersin.org
Introduction: The complement system is essential for an adequate immune response. Much
attention has been given to the role of complement in disease. However, to better …

Therapeutic potential of complement modulation

E Wagner, MM Frank - Nature reviews Drug discovery, 2010 - nature.com
The complement system is an essential component of innate immunity that has been more
recently recognized as an unexpected player in various pathological states. These include …

Compstatin: a complement inhibitor on its way to clinical application

D Ricklin, JD Lambris - Current Topics in Complement II, 2008 - Springer
Therapeutic modulation of the human complement system is considered a promising
approach for treating a number of pathological conditions. Owing to its central position in the …

[HTML][HTML] Tackling neuroinflammation after traumatic brain injury: Complement inhibition as a therapy for secondary injury

IAM van Erp, I Michailidou, TA van Essen… - …, 2023 - Elsevier
Traumatic brain injury (TBI) is a leading cause of mortality, sensorimotor morbidity, and
neurocognitive disability. Neuroinflammation is one of the key drivers causing secondary …

Recombinant C1 inhibitor in brain ischemic injury

R Gesuete, C Storini, A Fantin… - Annals of Neurology …, 2009 - Wiley Online Library
Abstract Objective C1 inhibitor (C1‐INH) is an endogenous inhibitor of complement and
kinin systems. We have explored the efficacy and the therapeutic window of the recently …

[HTML][HTML] Distinct in vitro complement activation by various intravenous iron preparations

JC Hempel, F Poppelaars, M Gaya da Costa… - American journal of …, 2017 - karger.com
Background: Intravenous (IV) iron preparations are widely used in the treatment of anemia in
patients undergoing hemodialysis (HD). All IV iron preparations carry a risk of causing …

Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary lumen reduction …

G Castellano, R Franzin, A Stasi, C Divella… - Frontiers in …, 2018 - frontiersin.org
Pericytes are one of the principal sources of scar-forming myofibroblasts in chronic kidneys
disease. However, the modulation of pericyte-to-myofibroblast transdifferentiation (PMT) in …

Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets

A Barratt-Due, SE Pischke, PH Nilsson… - Journal of Leucocyte …, 2017 - academic.oup.com
The host is protected by pattern recognition systems, including complement and TLRs,
which are closely cross-talking. If improperly activated, these systems might induce tissue …